Skip to main content

Researchers wake-up DNA from soil bacteria to discover novel acid antibiotic

· A large DNA fragment from a soil bacterium was captured and engineered to be awoken

· The researchers then used to trigger production of a novel natural product, an acid antibiotic, encrypted in that DNA was identified and characterised

· The discovered molecule, Scleric acid, could help combat bacteria and was shown to partially inhibit Mycobacterium tuberculosis, as well as the cancer-associated metabolic enzyme nicotinamide N-methyltransferase (NNMT).

Scleric Acid has been discovered by capturing and engineering a DNA fragment from soil bacteria Streptomyces sclerotialus, and could help fight bacterial infections - by researchers at the School of Life Sciences and Department of Chemistry, University of Warwick.

A team led by Dr Christophe Corre and Dr Manuela Tosin have had published in Chemical Science https://pubs.rsc.org/en/content/articlepdf/2019/SC/C8SC03814G the characterisation of a new bioactive natural product whose derivatives could be used as antibiotics and help fight infections.

The new molecule was encrypted in a silent cluster of genes in the soil bacterium Streptomyces sclerotialus (isolated in Pune – India) and discovered by turning on an otherwise silent pathway using a combination of bioinformatics analyses, CRISPR/Cas9 gene editing and analytic chemistry instrumentation.

Bioinformatics tools permit to identify proteins encoded in DNA sequences and to predict the ro

Antibiotic droplets produced by Streptomyces coelicolor grown on a Petri dish

le they may play. In the majority of studies aimed to discover new natural products, researchers look for conserved enzymes with homology to known biosynthetic machineries. In this study, conserved regulatory elements associated with biosynthetic genes were targeted. An approach expected to lead to the discovery of natural products assembled by truly novel types of biocatalysts.

The study revealed a structurally new class of natural product but also new biosynthetic enzymes that catalyse unique condensation reactions between the building blocks that make up scleric acid. Such enzymes may find future applications as biocatalysts for the manufacture of high value chemicals.

The expression and manipulation of the cluster of genes of interest was carried out in a secondary organism using quick and efficient CRISPR/Cas9-based gene editing technology. This means that there is no need to optimise a protocol for the engineering of the bacterial species of interest, and this approach can be extended to exploit gene clusters identified in genetically intractable bacteria or even in metagenomes (genetic material recovered directly from environmental samples).

The approach of engineering genetically silent pathways that bacteria are thought to “normally” use to outcompete other micro-organisms could result in the discovery of a wide variety of novel antimicrobial compounds – which could help solve the antibiotic resistance crisis.

The researchers then tested the scleric acid possible antibiotic powers and found that it showed moderate antibacterial activity against Mycobacterium tuberculosis (H37Rv), exhibiting a 32% inhibition on the growth of this strain. The scleric acid also showed inhibitory activity on the cancer associated metabolic enzyme nicotinamide N-methyltransferase (NNMT).

Dr Christophe Corre who is part of the Warwick Integrative Synthetic Biology Centre commented:

“Over the last decade, a combination of technological advances, in particular in DNA sequencing, bioinformatics tool development, microbial genetic engineering and analytical chemistry, has really changed the game. New strategies have been developed to exploit the genomes of bacteria and access a large untapped source of novel molecules with therapeutic potential, in particular to treat infectious diseases.

Using synthetic biology, our study has evidenced that breaking locks at the transcriptional level does trigger the production of truly novel bioactive substances. The next game-changer will be the successful implementation of automation and robotics to characterise the thousands of natural products that remain encrypted at the DNA level.”

ENDS

22 OCTOBER 2018

NOTES TO EDITORS

For further information please contact:

Alice Scott, Media Relations Manager – Science, University of Warwick
TEL: 02476 574255 or 07920531221
E-mail: alice.j.scott@warwick.ac.uk

High res images available:

https://warwick.ac.uk/services/communications/medialibrary/images/october2018/christophe_corre.jpg

https://warwick.ac.uk/services/communications/medialibrary/images/october2018/strepto110609_007_002.jpg

For further information please contact:

Alice Scott, Media Relations Manager – Science, University of Warwick
TEL: 02476 574255 or 07920531221
E-mail: alice dot j dot scott at warwick dot ac dot uk

You can find the paper at:

https://pubs.rsc.org/en/content/articlepdf/2019/SC/C8SC03814G